Study of the Penumbra Coil 400 System to Treat Aneurysm (ACE)
ACE: An Aneurysm Coiling Efficiency Study of the Penumbra Coil 400 System
Sponsor: Penumbra Inc.
Listed as NCT01465841, this NA trial focuses on Intracranial Aneurysms and Peripheral Aneurysms and remains completed. Sponsored by Penumbra Inc., it has been updated 12 times since 2011, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Jan 2026 — Present [monthly]
Completed NA
-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
▶ Show 7 earlier versions
-
Jan 2021 — Dec 2022 [monthly]
Completed NA
-
Aug 2020 — Jan 2021 [monthly]
Completed NA
Phase: PHASE4 → NA
-
Jan 2019 — Aug 2020 [monthly]
Completed PHASE4
Status: Unknown Status → Completed
-
Oct 2018 — Jan 2019 [monthly]
Unknown Status PHASE4
Status: Active Not Recruiting → Unknown Status
-
Jun 2018 — Oct 2018 [monthly]
Active Not Recruiting PHASE4
-
Feb 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE4
First recorded
Nov 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Penumbra Inc.
For direct contact, visit the study record on ClinicalTrials.gov .